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The ability of memory T lymphocytes derived from latently infected mice to control murine cytomegalovirus
disease in the immunocompromised host was studied by adoptive transfer experiments. At a stage of
pathogenesis when virus had already colonized target tissues, a therapeutic antiviral function could be ascribed
to the CD8+ subset. This in vivo function was not restricted to sites in which intravenously infused lymphocytes
usually are trapped or home in, such as the lungs or the spleen, respectively, but was also evident in the adrenal
glands, a site to which antiviral effector cells have to specifically migrate. Specific infiltration of adrenal gland
cortical tissue by donor-derived CD8+ memory T lymphocytes was demonstrated. CD4+ memory T
lymphocytes had no antiviral effect by themselves and also were not required for the function of the CD8+
effector cells in this short-term immunotherapy model. These findings should help settle the debate about which
subset of T lymphocytes comprises the effector cells that can directly control cytomegalovirus infection in the
murine model system.
Cytomegalovirus (CMV) latency is controlled by antiviral
immunity. Only in the immunocompromised host does pri-
mary CMV infection or CMV recurrence result in severe
disease. In bone marrow transplant recipients with opportu-
nistic human CMV infections, interstitial pneumonia is con-
sidered the immediate cause of death (8), but other tissues
are also affected, and serious CMV adrenalitis has been
observed in a murine model system (15, 16). For patients
with acquired immunodeficiency syndrome, CMV disease is
one of the leading causes of mortality (7, 9), and adrenal
necrosis with presumed herpesvirus etiology is a life-threat-
ening symptom (17).
As a model for human CMV disease in iatrogenically
immunocompromised patients, we studied murine CMV
(MCMV) disease after immunodepletion by total-body y
irradiation of mice of the BALB/c strain. Previous work (12,
14) has demonstrated that T lymphocytes, obtained from
draining popliteal lymph nodes of immunocompetent mice
during an acute intraplantar infection with MCMV, can limit
virus multiplication in tissues of immunodeficient cell trans-
fer recipients. Such T lymphocytes were protective not only
when given prophylactically before infection, but also when
applied therapeutically after MCMV had colonized host
tissues. So far, it has been shown for the lungs (14) and for
the spleen (12) that the antiviral effect of T lymphocytes is a
function of the CD4- CD8+ subset and that low numbers of
CD4- CD8+ cytolytic effector cells specific for immediate-
early membrane antigens of MCMV (5, 6, 10, 11) prevent
lung tissue destruction and mediate survival (13).
On the basis of these findings, it was assumed that also in
other tissues CD8+ but not CD4+ T lymphocytes comprise
the antiviral effector cells. This assumption contradicts
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recent results of Shanley (15), who used the T-lymphocyte-
deficient athymic nulnu mutant of BALB/c mice as cell
transfer recipient and concluded that in the adrenal glands,
MCMV infection is controlled only by the CD4+ CD8-
subset of T lymphocytes.
Two hypotheses can be proposed to explain this discrep-
ancy: either the effector mechanisms of protective immunity
are different in the two model systems, or different T-
lymphocyte subsets are responsible for controlling CMV
infection at different sites. An experimental verification of
either of these explanations would be of obvious interest for
the understanding of CMV pathogenesis. These consider-
ations prompted us to identify in our model system the
T-lymphocyte subset that controls adrenal gland infection.
To ascertain that MCMV pathogenesis in irradiated wild-
type BALB/c (12-14) and nude mutant (15, 16) mice is not
disparate, we studied the histopathology of the adrenal
glands (Fig. la and b). At day 14 after irradiation and
intraplantar infection, at a time when mortality was already
pronounced (13, 14), focal necroses were found rarely in the
medulla but frequently throughout the cortex. Figure la
shows an extended necrosis in the reticular zone adjacent to
the medulla. By electron microscopy (Fig. lb), stages of
MCMV virion morphogenesis, including the formation of
multicapsid virions, (18) were identified in a parenchymal
cell of the reticular zone. In essence, virus multiplication and
adrenalitis was also demonstrated in the irradiated host.
A therapeutic antiviral function during an established
infection of tissue demands the presence of effector cells at
the infected sites. It is known that lymphocytes administered
in the caudal vein are trapped in the lungs (for a review, see
reference 4), and it has been documented for other adoptive
transfer models that donor-type T lymphocytes do home in
lymphoid tissues, where they persist for long terms as
memory cells (1). While an antiviral effect in the lungs and
spleen of the recipient may therefore not require site-
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FIG. 1. Demonstration of adrenalitis and infiltration of the adrenal gland cortex by CD8' T lymphocytes. Adrenal gland tissue was isolated
at day 14 p.i. (a and b) or at day 12 p.i. (c and d) from BALB/c mice infected in the footpad with 105 PFU of MCMV (strain Smith, ATCC
VR-194) after immunodepletion by total-body y irradiation with a single radiation dose of 6 Gy (14). (a) Paraffin section (5 ,um) stained with
hematoxylin and eosin and examined by light microscopy (bar, 30 ,um), showing a pronounced focal necrosis in the zona reticularis of the
cortex. M, Medulla; C, cortex. Infected parenchymal cells with characteristic inclusion bodies (arrows) are found in the periphery. (b)
Electron micrograph (14, 18) showing stages of MCMV virion morphogenesis in an infected parenchymal cell (bar, 1 ,um). The assembly of
nucleocapsids in the nucleus (arrowheads) and the formation of multicapsid virions by budding of cytoplasmic nucleocapsid clusters into
cytoplasmic vacuoles (arrows) are shown. (c and d) CD8+ memory T lymphocytes (2 x 107) infused i.v. at day 6 p.i. Cells infiltrating the
adrenal gland cortex were visualized immunohistologically in cryostat sections (8 ,um) of frozen tissue by direct immunofluorescence with
fluorescein isothiocyanate-labeled rat Mab anti-Lyt-2 (no. 1353; Becton Dickinson and Co.) (c) and by indirect immunoenzymatic staining
with mouse Mab anti-Lyt-2.2 (hybridoma 19/178 [13, 14]) and alkaline phosphatase-conjugated F(ab')2 fragments of goat anti-mouse IgG (no.
115-055-072; Jackson Immuno-Research) with naphthol-As-MX-phosphate as substrate and fast blue BB as coupling agent (Fluka AG, Buchs,
Switzerland) (d). The arrow in panel d points to membrane-stained cells. Panels c and d are shown at the same magnification (bar, 30 ,um).
directed migration of transferred T lymphocytes, specific
infiltration of infected tissue is needed for an antiviral
function of effector T lymphocytes in the adrenal glands.
To test whether the reported failure of CD8+ T lympho-
cytes to cope with adrenal gland infection (15) is caused by
an inability to infiltrate that tissue, we transferred at day 6
postinfection (p.i.), at a time when virus had colonized
adrenal gland tissue (unpublished observation), CD8+ T
lymphocytes derived either from spleens of latently infected
donors (for explanation, see below) or, for control, from
spleens of noninfected donors. In neither case was infiltra-
tion demonstrated before day 4 after transfer (day 10 p.i.). At
day 6 after the transfer of nonimmune cells, only a few CD8+
T lymphocytes became detectable by screening a series of
sections (not depicted), whereas after the transfer of mem-
ory cells, infiltrating CD8+ T lymphocytes were readily seen
by different techniques in the multiformic and fascicular
zones of the adrenal gland cortex (Fig. lc and d). Single cells
were also found scattered in the reticular zone. The delayed
appearance of donor-derived cells and the ready detection of
cells derived from latently infected donors strongly suggest a
directed infiltration by antigen-specific T lymphocytes.
Thus, this part of our study did not reveal any reason that
CD8+ T lymphocytes should not be operative in adrenal
gland tissue also.
By measuring the virus titers in tissues, we confirmed our
previous finding that CD8+ T lymphocytes comprise antivi-
ral effector cells operative in the lungs and in the spleen
(12-14) and proved that in this respect the adrenal glands are
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FIG. 2. Identification of the memory T-lymphocyte subset operating in a short-term antiviral immunotherapy model. Memory cells of
either T-lymphocyte subset or defined mixtures of both were transferred i.v. into irradiated (6 Gy; -y irradiation) and infected (105 PFU of
MCMV) recipients at day 6 p.i., i.e., according to the therapeutic schedule (12, 14). *, Individual titers in tissues determined at day 14 p.i.;
-, median values. The detection level (DL) was 100 PFU per organ. The proportion of recipients that had survived until the day of assay
is given in the left panel. Columns: A, no transfer of lymphocytes (code 0/0); B, transfer of 106 T lymphocytes depleted of the CD4+ subset
(code 1/0); C, transfer of 106 T lymphocytes depleted of the CD8+ subset (code 0/1); D to F, transfer of mixtures of both subsets composed
as indicated.
We applied the therapeutic lymphocyte transfer protocol
essentially as previously described (14), except that memory
T lymphocytes were used instead of acutely sensitized
lymphocytes. Spleens of 10-month-old latently infected
BALB/c mice, infected the day after birth intraperitoneally
with 100 PFU of MCMV (10), were taken as sources of
memory T lymphocytes. Latent infection of the donors was
ascertained by detecting recurrent virus in salivary glands
after radiation-induced (6 Gy) reactivation (incidence of
recurrence, 37%; data not shown). It is notable that the
generation of cytolytic effector cells in memory T-lympho-
cyte populations requires specific restimulation (10), and
thus it is expected that transferred memory cells must
encounter antigen in the recipient to function. We have
chosen this modified protocol because it allows us to evalu-
ate the ability of memory T lymphocytes to cope with virus
reactivation from latency.
The procedure was carried out as follows. Memory T
lymphocytes were purified by nylon-wool depletion of B
lymphocytes and accessory cells and depleted of the CD4+
and CD8+ subsets by treatment with monoclonal antibody
(Mab) anti-L3T4a (GK 1.5, rat immunoglobulin G2b (IgG2b)
and anti-Lyt-2.2 (hybridoma 19/178, mouse IgG2a), respec-
tively (14). The purities of the resulting CD8+ and CD4+
populations were controlled by flow cytometric analysis (not
shown) as described previously (13). In all three tissues
tested, the transfer of CD8+ T lymphocytes at day 6 p.i.
significantly limited virus multiplication, as assessed by
determining the virus titers in individual recipients at day 14
p.i. (Fig. 2, compare columns A and B [P < 0.001 by the
one-sided Wilcoxon-Mann-Whitney exact rank sum test]).
The transfer of the same number of CD4+ T lymphocytes
had no antiviral effect (Fig. 2, compare columns A and C [P
> 0.05]). In agreement with previous results (12), the anti-
viral efficacy of therapeutically transferred cells was lower in
the adrenal glands than in the lungs and spleen (Fig. 2,
compare the respective panels), while prophylactic transfer
was most effective in protecting against adrenal gland infection
(12). An explanation may be that prophylactic transfer prevents
the colonization of tissue by virus, whereas during established
tissue infection, the delayed infiltration of the adrenal glands by
effector T lymphocytes limits the time available for their
operation in a short-term immunotherapy model.
We asked further whether memory CD4+ T lymphocytes
enhance the antiviral efficacy of memory CD8+ T lympho-
cytes by providing help (Fig. 2, columns D to F). There was
no indication of a helper effect when graded numbers of
CD4+ T lymphocytes were transferred with a constant
number of CD8+ T lymphocytes (Fig. 2, compare columns B
and D to F [P > 0.05]). It is notable that CD4+ memory T
lymphocytes were operative when transferred with memory
B lymphocytes, as monitored by helper-dependent serocon-
version in the transfer recipient (data not shown). These data
already strongly suggested that, at least for a short-term
function, CD8+ memory T lymphocytes do not require help
from CD4+ T lymphocytes.
It could be argued, however, that help is delivered by
putative radiation-resistant helper cells of recipient type or
by helper cells generated by autoreconstitution during the 6
days between irradiation and therapeutic lymphocyte trans-
fer. To exclude this possibility, the irradiated and infected
recipients received intravenous (i.v.) infusions of anti-CD4
Mab (GK 1.5, anti-L3T4a [3]) for an in vivo depletion of
CD4+ T lymphocytes (Table 1), a strategy established by
Cobbold and colleagues (2). The antibody was administered
6 h before cell transfer, and to prolong the helper-depleted
state, a second dose was given 2 days later. This regimen
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TABLE 1. CD4-helper-independent therapeutic antiviral function of CD8' memory T lymphocytes
Experimental regimen' Median value (n = 4) of virus titers (log10 PFU) in:
Group Irradiation and Transfer cxCD4 in vivo' Lungs Spleen Adrenal glands




C + + + 4.6 3.2 3.6
a Purified CD8+ memory T lymphocytes (2 x 106) were infused i.v. at day 6 p.i. into irradiated (6 Gy; y irradiation) and infected (10' PFU ofMCMV) recipients.
Virus titers in tissues were measured at day 14 p.i.
b For in vivo depletion of CD4+ T lymphocytes, 0.8 mg Mab GK 1.5 (anti-L3T4, rat IgG2b [31) contained in 2 mg of protein from partially purified ascites was
administered i.v. 6 h before cell transfer. Dose 2 was given 2 days thereafter.
lymphocytes, as judged by cytofluorometric analysis of
spleen and lymph node cells (data not shown).
The transfer of CD8+ T lymphocytes also significantly
limited virus multiplication in recipients depleted of putative
residual CD4+ helper cells (Table 1, compare groups A and
C [P = 0.025 in all tissues tested]), and the antiviral efficacy
of lymphocyte transfer was not significantly lowered (Table
1, compare groups B and C [P > 0.1 in lungs and spleen and
P = 0.1 in adrenal glands]). We arrived at the same conclu-
sion when we transferred nonseparated memory T lympho-
cytes and eliminated either the CD4+ or the CD8+ subset in
vivo by infusing the respective antibodies (data not shown).
These experiments thus demonstrated that CD8+ memory T
lymphocytes can operate in the transfer recipient also in the
absence of helper cells of the CD4+ subset.
In conclusion, our study has shown that memory T
lymphocytes of the CD8+ subset can infiltrate adrenal gland
tissue and can control infection also at that site, whereas
CD4+ T lymphocytes do not exert a direct antiviral effect,
nor are they essential as helper cells.
These findings are contrary to the conclusion drawn by
Shanley from his experiments with the nude mouse model
for CMV disease, in which sorted T-lymphocyte subsets
were used for adoptive transfer (15). While we have now
disproven the hypothesis that at different sites different
T-lymphocyte subsets control MCMV infection, the possi-
bility that the effector mechanisms of antiviral control differ
in the two experimental models can still account for the
obvious discrepancy. The main difference between the mod-
els is the presence of B lymphocytes and accessory cells, as
well as natural killer cells, in nude mice. One interpretation
could be that the antiviral effect of donor CD4+ T lympho-
cytes observed by Shanley (15) has been mediated by one of
these recipient cell types. However, before a final conclu-
sion is reached, we think that a critical review of the
experimental details of cell sorting may be useful. It is a
disadvantage of positive selection that binding of antibodies
causes the depletion of stained cells in vivo by opsonization
(S. P. Cobbold and H. Waldmann, circulatory letter with
recommendations for the use of rat IgG2b Mab to mouse
T-lymphocyte subsets). In addition, the use of irreversible
metabolic inhibitors to prevent antigen modulation (15) must
be expected to negatively affect the ability of sorted cells to
operate in vivo thereafter.
With respect to our previous hypothesis that cytolytic- T
lymphocytes of the CD8+ subset are involved in preventing
CMV recurrence in latently infected hosts (11), our present
study gave the important new information that CD8+ mem-
ory T lymphocytes derived from latently infected mice can
indeed control MCMV multiplication as efficiently as or even
better than acutely sensitized lymphocytes do (12, 14).
The finding that this function can be performed also in the
absence of CD4+ T lymphocytes may be of interest for the
prevention of opportunistic CMV infection in CD4-subset-
deficient patients with acquired immunodeficiency syn-
drome.
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